| Bristol-Myers Squibb, making its largest RE investment ever at the $750M, 300k SF Ft. Devens manufacturing complex, earned its first LEED designation last month. Its biopharma lab and office went Gold. The building will reduce greenhouse gas emissions (doesn't BMS make a drug for gas emissions, too?) and save on energy costs with its lighting, heating and cooling systems, water, and materials use. BMS also hopes that its just completed new factory at Devens will win a LEED green light sometime this summer, a rare feat for a biopharma manufacturing plant. |
Sign up for more articles like this
Subscribe to Bisnow's Boston Newsletters
Related Stories
)
)
)
)
)
)
)
)
)
)
)
)